PRINCIPAL FINANCIAL GROUP INC
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1126328
DES MOINES, IA
Position in ACAD
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$19,966,658
+$2,865,993 QoQ
Shares Held
789,196
+2.7% QoQ
Ownership
0.458%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#34
of 354 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRINCIPAL FINANCIAL GROUP INC holds $1,857,842,341 across 105 Biotechnology names. ACAD ranks #28 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
873,502 | $232,980,453 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
389,511 | $193,481,798 | |
| 3 | CYTK |
Cytokinetics Inc
|
1,311,664 | $111,740,655 | |
| 4 | GPCR |
Structure Therapeutics Inc.
|
1,752,753 | $94,070,253 | |
| 5 | INSM |
INSMED Inc
|
856,126 | $91,280,154 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
332,642 | $81,420,782 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,024,423 | $76,299,024 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
121,053 | $75,481,386 |
All Filings in ACAD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,966,658 | 789,196 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $17,100,665 | 768,224 | Shares | Defined | 2026-05-04 | |
| 2025-12-31 | $19,908,458 | 745,356 | Shares | Defined | 2026-02-02 | |
| 2025-09-30 | $14,865,401 | 696,598 | Shares | Defined | 2025-11-04 | |
| 2025-06-30 | $15,318,194 | 710,162 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $12,536,363 | 754,748 | Shares | Defined | 2025-04-28 | |
| 2024-12-31 | $2,636,784 | 143,694 | Shares | Defined | 2025-01-31 | |
| 2024-09-30 | $1,992,494 | 129,551 | Shares | Defined | 2024-10-31 | |
| 2024-06-30 | $1,254,678 | 77,211 | Shares | Defined | 2024-07-29 | |
| 2024-03-31 | $1,567,877 | 84,796 | Shares | Defined | 2024-04-29 | |
| 2023-12-31 | $3,012,459 | 96,214 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $1,628,437 | 78,140 | Shares | Defined | 2023-11-02 | |
| 2023-06-30 | $1,513,208 | 63,182 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $1,255,914 | 66,733 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $1,193,569 | 74,973 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $1,081,362 | 66,098 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $1,668,297 | 118,403 | Shares | Defined | 2022-08-10 | |
| 2022-03-31 | $977,252 | 40,349 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $921,112 | 39,465 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $960,772 | 57,843 | Shares | Defined | 2021-11-09 | |
| 2021-06-30 | $1,367,888 | 56,084 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $1,243,327 | 48,191 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $2,463,436 | 46,080 | Shares | Defined | 2021-02-23 | |
| 2020-09-30 | $1,927,447 | 46,726 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $2,742,674 | 56,585 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $2,775,149 | 65,684 | Shares | Defined | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||